Derivative Liabilities - Fair Value
Medtronic Derivative Liabilities - Fair Value increased by 11.2% to $388.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 391.1%, from $79.00M to $388.00M. Over 4 years (FY 2021 to FY 2025), Derivative Liabilities - Fair Value shows a downward trend with a -24.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase in liabilities suggests unfavorable market movements for the company's hedges, while a decrease indicates a reduction in potential settlement obligations.
Detailed definition
This represents the fair value of derivative financial instruments that are currently in a liability position. These lia...
Peer comparison
Standard for energy companies; peers with similar hedging profiles will show comparable volatility in this line item.
derivative_liabilities_fair_valueHistorical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $296.00M | $181.00M | $163.00M | $61.00M | $20.00M | $20.00M | $18.00M | $267.00M | $236.00M | $306.00M | $24.00M | $109.00M | $66.00M | $98.00M | $110.00M | $79.00M | $97.00M | $523.00M | $349.00M | $388.00M |
| QoQ Change | — | -38.9% | -9.9% | -62.6% | -67.2% | +0.0% | -10.0% | >999% | -11.6% | +29.7% | -92.2% | +354.2% | -39.4% | +48.5% | +12.2% | -28.2% | +22.8% | +439.2% | -33.3% | +11.2% |
| YoY Change | — | — | — | — | -93.2% | -89.0% | -89.0% | +337.7% | >999% | >999% | +33.3% | -59.2% | -72.0% | -68.0% | +358.3% | -27.5% | +47.0% | +433.7% | +217.3% | +391.1% |
Derivative Liabilities - Fair Value at Other Companies
Frequently Asked Questions
- What is Medtronic's derivative liabilities - fair value?
- Medtronic (MDT) reported derivative liabilities - fair value of $388.00M in Q4 2025.
- How has Medtronic's derivative liabilities - fair value changed year-over-year?
- Medtronic's derivative liabilities - fair value increased by 391.1% year-over-year, from $79.00M to $388.00M.
- What is the long-term trend for Medtronic's derivative liabilities - fair value?
- Over 4 years (2021 to 2025), Medtronic's derivative liabilities - fair value has grown at a -24.3% compound annual growth rate (CAGR), from $296.00M to $97.00M.
- What does derivative liabilities - fair value mean?
- The total market value of all derivative contracts that are currently resulting in a loss.